The Aetiology of Mirror Writing:A New Hypothesis
JNNP 50:1572-1578, Tashiro,K.,et al, 1987
Progressive Supranuclear Palsy & a Multi-Infarct State
Neurol 37:570-576, Dubinsky,R.M.&Jankovic,J., 1987
Caffeine & Tremor
Neurol 37:169-172, Koller,W.,et al, 1987
Neurologic Aspects of Boxing
Arch Neurol 44:453-459, Jordan,B.D., 1987
Movement Disorders & AIDS
Neurol 37:37-41, Nath,A.,et al, 1987
Calcium Channels & Calcium Channel Antagonists
Ann Neurol 21:317-330, Greenberg,D.A., 1987
A Case of Normal Pressure Hydrocephalus Presenting as Levodopa Responsive Parkinsonism
JNNP 50:234, Clough,C.G., 1987
Progression of Parkinson's Disease Without Levodopa
Neurol 37:695-698, Coetz,C.G.,et al, 1987
Juvenile Parkinsonism:Clinical & Metabolic Characteristics
JNNP 50:345-348, Lima,B.,et al, 1987
Parkinson's Disease & Dementia:Norepinephrine & Dopamine in Locus Ceruleus
Neurol 37:42-46, Cash,R.,et al, 1987
Open Microsurgical Autograft of Adrenal Medulla to Caudate Nucleus in Two Pts with Intrac Parkinson's Dis
NEJM 316:831-834, 872-8731987., Madrazo,I.,et al, 1987
Update on Parkinson Disease
NY State J Med, 87:147-1531987., Lieberman,A.N., 1987
Postprandial & Orthostatic Hypotension in Parkinson's Disease
Neurol 37:386-393, Micieli,G.,et al, 1987
Spatial Disorientation as an Early Symptom of Parkinson's Disease
Neurol 37:485-487, Hovestadt,A.,et al, 1987
Akathisia in Idiopathic Parkinson's Disease
Neurol 37:477-481, Lang,A.E.&Johnson,K., 1987
Controlled-Release Levodopa/Carbidopa. I. Sinemet CR3 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:233-241, Cedarbaum,J.M.,et al, 1987
Controlled Release Levodopa Treatment of Motor Fluctuations in Parkinson's Disease
JNNP 50:194-198, Juncos,J.L.,et al, 1987
Influence of Dietary Protein on Motor Fluctuations in Parkinson's Disease
Arch Neurol 44:270-272, Pincus,J.H.&Barry,K., 1987
Disorders of the Autonomic Nervous System:Part 1. Pathophysiology & Clinical Features
Ann Neurol 21:419-430, McLeod,J.G.&Tuck,R.R., 1987
Perseveration in Behavioral Neurology
Neurol 37:1736-1741, Sandson,J.&Albert,M.L., 1987
Limb Dystonia in Progressive Supranuclear Palsy
Neurol 37:1546-1549, Rafal,R.D.&Friedman,J.H., 1987
Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987
Flunarizine- & -Cinnarizine-Induced Extrapyramidal Reactions
Neurol 37:881-884, Micheli,F.,et al, 1987
Aggravation of Parkinson's Disease by Cinnarizine
JNNP 50:804-805, Marti-Masso,J.F.,et al, 1987
Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987
Factors that Influence the Occurrence of Response Variations in Parkinson's Disease
Ann Neurol 22:4-7, deJong,G.J.,et al, 1987
Multi-Center Study of Parkinson Mortality with Early Versus Later Dopa Treatment
Ann Neurol 22:8-12, Diamond,S.G.,et al, 1987
Adjuvant Therapy of Parkinsonian Tremor
Arch Neurol 44:921-923, Koller,W.C.&Herbster,G., 1987
Neuropsychological Disturbances in Hemiparkinson's Disease
Neurol 37:1762-1764, Starkstein,S.,et al, 1987
Parkinson's Disease:Sensory & Motor Problems in Arms & Hands
Neurol 37:951-956, Schneider,J.S.,et al, 1987
Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987
Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987
Forms of Dystonia in Patients with Parkinson's Disease
Neurol 37:1009-1011, Kidron,D.&Melamed,E., 1987
Clinical & Biochemical Correlates of Bradyphrenia in Parkinson's Disease
Neurol 37:1130-1134, Mayeux,R.,et al, 1987
Neuropathologic & Clinical Features of Parkinson's Disease in Alzheimer's Disease Patients
Neurol 37:754-760, Ditter,S.M.&Mirra,S.S., 1987
Adrenal Grafts for Parkinson's Disease
Letter, NEJM 317:1091-10931987., , 1987
Transplantation in Parkinson's Disease:Two Cases of Adrenal Medullary Grafts to the Putamen
Ann Neurol 22:457-468, Lindvall,O.,et al, 1987
Neural Transplants:Are We Ready
Ann Neurol 22:455-456, Joynt,R.J.&Gash,D.M., 1987
Management of Parkinson's Disease
BMJ 294:1393-1396, Gibberd,F.B., 1987
Parkinson's Disease & Motor Fluctuations:Long-Acting Carbidopa. Levodopa (CR-4-Sinemet)
Neurol 37:875-878, Goetz,C.G.,et al, 1987
Controlled-Release Levodopa/Carbidopa. II. Sinemet CR4 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:1607-1612, Cedarbaum,J.M.,et al, 1987
Controlled Release Levodopa-Carbidopa (CR-5) in the Management of Parkinsonian Motor Fluctuations
Arch Neurol 44:1010-1012, Juncos,J.L.,et al, 1987
Dietary Influence on the Antiparkinsonian Response to Levodopa
Arch Neurol 44:1003-1005, Juncos,J.L.,et al, 1987
Plasma Levels of Amino Acids Correlate with Motor Fluctuations in Parkinsonism
Arch Neurol 44:1006-1009, Pincus,J.H.&Barry,K.M., 1987
Dietary Therapy for Motor Fluctuations in Parkinson's Disease
Arch Neurol 44:1119-1121, Kurlan,R., 1987
Pathophysiol Clin Assess of Motor Symptoms in PD, Jankovic in Handbook of Parkinson's Disease, Ed W. C. Koller
New York 1987, p. 118-120, 475-488., Marcel Dekker,Inc., 1987
Parkinson's Disease & Myasthenia Gravis:Adverse Effect of Trihexyphenidyl on Neuromuscular Transmission
Neurol 37:832-833, Ueno,S.,et al, 1987
Parkinson's Disease & Pregnancy
Neurol 37:1245-1249, Golbe,L.I., 1987
Parkinson's Disease & Megacolon:Concentric Hyaline Inclusions (Lewy Bodies) in Enteric Ganglion Cells
Neurol 37:1253-1255, Kupsky,W.J.,et al, 1987
Levodopa Methyl Ester Treatment of Parkinson's Disease
Neurol 37:1242-1245, Juncos,J.L.,et al, 1987